Delivery Order SPE2DB22D1202-SPE2DB25FVLC2
- Not listed
- AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, was awarded a delivery order valued at $44,617.14 by the Defense Logistics Agency on September 11, 2025, for the supply of Dupixent 300 mg/2 mL pen injectors. The contract is a firm fixed-price delivery order with an ultimate completion date of September 12, 2025, and represents a non-set-aside competitive award. This delivery order is issued under AmerisourceBergen's larger Indefinite...
- AmerisourceBergen Drug Corp was awarded a delivery order valued at $22,154.31 by the Defense Logistics Agency (DLA) on September 3, 2025, for the supply of Dupixent 300 mg/2 ml pens. This firm fixed price, competitively awarded contract is a non-set-aside delivery order with an ultimate completion date of September 4, 2025, and will be performed at the contractor's Conshohocken, Pennsylvania location. The award represents a child delivery order under AmerisourceBergen's larger Indefinite...
- AmerisourceBergen Drug Corp was awarded a delivery order valued at $12,141.94 by the Defense Logistics Agency (DLA) on July 28, 2025, for the supply of Dupixent 300 mg/2 mL pens. This is a firm fixed price, non-set-aside contract with an ultimate completion date of July 29, 2025, and will be performed at the contractor's corporate office location in Conshohocken, Pennsylvania. The delivery order is issued under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support...
- AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, was awarded a delivery order by the Defense Logistics Agency (DLA) on August 18, 2025, for the supply of Dupixent 300 mg/2 ml pen injections with a ceiling value of $3,418.92. This is a firm fixed-price delivery order under a non-set-aside competitive procurement, with an ultimate completion date of August 19, 2025. The contract represents a continuation of AmerisourceBergen's role as a critical pharmaceutical supplier...
- AmerisourceBergen Drug Corp was awarded a delivery order by the Defense Logistics Agency (DLA) on August 22, 2025, for the supply of Dupixent 300 mg/2 mL pen injectors with a ceiling value of $18,961.13. This is a firm fixed price, non-set-aside contract with an ultimate completion date of August 25, 2025, and performance based in Conshohocken, Pennsylvania. The delivery order is issued under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), a...
- The Defense Logistics Agency awarded a delivery order valued at $5,987.47 to AmerisourceBergen Drug Corp for the supply of Dupixent 300 mg/2 ml pen injectors on August 5, 2025, with an ultimate completion date of August 6, 2025. This competitive award, issued under firm fixed pricing, represents a child contract to AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 and extending through December 2026. The place of...
- AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, received a competitive delivery order award from the Defense Logistics Agency (DLA) on July 21, 2025, for the supply of Dupixent 300 mg/2 ml pen injectors. This firm fixed-price delivery order, valued at $8,700.31, is scheduled for completion by July 22, 2025, and represents a component of the company's broader pharmaceutical supply relationship with the federal government. The award carries no set-aside designation and...
- The Defense Logistics Agency awarded a delivery order valued at $17,964.65 to AmerisourceBergen Drug Corp for the supply of Dupixent 300 mg/2 mL pen injections on August 28, 2025, with an ultimate completion date of August 29, 2025. The contract utilizes firm fixed price pricing with no set-aside designation, indicating competitive award. AmerisourceBergen's corporate office in Conshohocken, Pennsylvania will serve as the place of performance for this pharmaceutical delivery. This delivery order...
- AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, was awarded a delivery order on August 4, 2025, by the Defense Logistics Agency (DLA) for Dupixent 200 mg/1.14 ml pen auto-injectors. The contract is valued at $1,935.84 with a firm fixed price structure and an ultimate completion date of August 5, 2025. This non-competitive delivery order was issued under AmerisourceBergen's existing Indefinite Delivery Contract (IDC) with DLA Troop...
- The Defense Logistics Agency (DLA) awarded a $16,338.29 delivery order to AmerisourceBergen Drug Corp for Dupixent 300 mg/2 mL pen injectors under a firm fixed-price contract type. This award, issued on September 2, 2025, with an ultimate completion date of September 3, 2025, represents a non-competitive delivery against an existing indefinite delivery contract. AmerisourceBergen, headquartered in Conshohocken, Pennsylvania, serves as a critical pharmaceutical distributor for federal medical...
- SPE2DB22D1202Indefinite Delivery Contract
- SPE2DB22D1202-SPE2DB25FVLC2Delivery Order
AmerisourceBergen Drug Corp was awarded a delivery order valued at $16,770.06 by the Defense Logistics Agency (DLA) on September 11, 2025, for the supply of Dupixent (dupilumab) 300 mg/2 mL pen injectors. This is a firm fixed-price, non-set-aside competitive award with an ultimate completion date of September 12, 2025. The pharmaceutical will be delivered to the Conshohocken, Pennsylvania location, which serves as AmerisourceBergen's corporate headquarters and distribution hub for federal medical procurement operations. This delivery order represents a task order issued under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued at $999,999,999.00 through December 2026. The prime IDC serves as a comprehensive global pharmaceutical support vehicle enabling the company to supply a broad range of medications and medical supplies to support military healthcare programs worldwide. AmerisourceBergen is a major pharmaceutical distributor and critical federal vendor for the Defense Health Agency and other government healthcare systems, with an established track record of fulfilling competitive federal medical supply requirements across multiple therapeutic domains.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $16.8k | 9/11/25 |